Azpire Pharma Private Limited - Company Profile

It is a pharma private limited company based in Lower Parel, Maharashtra, India, established in 2019.
2019 Lower Parel, Maharashtra, India Active
Last Updated:
Access Report
About Azpire Pharma Private Limited

Azpire Pharma Private Limited, a active private limited company, was established on 24 June 2019 in Lower Parel, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24299MH2019PTC327162. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Riddhi Sahil Javeri (Director), Sahil Sagar Javeri (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-3, Floor-G, A, Todi Industrial Estate, Sitaram Jadhav Marg, Sun Mill Compound,, Lower Parel, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299MH2019PTC327162

  • Registration Number

    327162

  • Incorporation Date

    24 June 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -68.42%
  • Profit Growth **** -111.08%
  • Ebitda **** -572.92%
  • Net Worth -97.31%
  • Total Assets -21.58%
Company report

Azpire Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Azpire Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Azpire Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Riddhi Sahil Javeri Director 24 Jun 2019 Current
Sahil Sagar Javeri Director 24 Jun 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Azpire Pharma.

Azpire Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.42% decrease. The company also saw a substantial fall in profitability, with a 111.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 97.31%.

Azpire Pharma revenue growth over time
Azpire Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -68.42%
*******
*******
*******
*******
Revenue from Operations
*******
 -68.71%
*******
*******
*******
*******
Total Assets
*******
 -21.58%
*******
*******
*******
*******
Profit or Loss
*******
 -111.08%
*******
*******
*******
*******
Net Worth
*******
 -97.31%
*******
*******
*******
*******
EBITDA
*******
 -572.92%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Azpire Pharma?

Unlock access to Azpire Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Azpire Pharma?

Unlock and access historical data on people associated with Azpire Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Azpire Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azpire Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Azpire Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Azpire Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Azpire Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Riddhi Sahil Javeri was appointed as a Director was appointed as a Director on 24 Jun 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.

  • Director Appointment

    Sahil Sagar Javeri was appointed as a Director was appointed as a Director on 24 Jun 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Azpire Pharma Private Limited was registered on 24 Jun 2019 with Roc Mumbai & aged 6 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Azpire Pharma Private Limited?

The CIN of Azpire Pharma Private Limited is U24299MH2019PTC327162.

Where is Azpire Pharma Private Limited headquartered?

Azpire Pharma Private Limited is headquartered at A-3, Floor-G, A, Todi Industrial Estate, Sitaram Jadhav Marg, Sun Mill Compound,, Lower Parel, Maharashtra, 400013.

When was Azpire Pharma Private Limited incorporated?

Azpire Pharma Private Limited was incorporated on 24 June 2019.

Who are the current directors of Azpire Pharma Private Limited?

The current directors of Azpire Pharma Private Limited are

What is the primary industry of Azpire Pharma Private Limited?

The primary industry of Azpire Pharma Private Limited is Manufacturing.

Is Azpire Pharma Private Limited a listed company?

Azpire Pharma Private Limited is unlisted.

What is the capital structure of Azpire Pharma Private Limited?

The authorized capital of Azpire Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available